These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11154124)

  • 1. Factor XIII Val34Leu polymorphism and risk of deep vein thrombosis.
    Margaglione M; Bossone A; Brancaccio V; Ciampa A; Di Minno G
    Thromb Haemost; 2000 Dec; 84(6):1118-9. PubMed ID: 11154124
    [No Abstract]   [Full Text] [Related]  

  • 2. The FXIII Val 34 Leu mutation and the risk of venous thrombosis.
    Alhenc-Gelas M; Reny JL; Aubry ML; Aiach M; Emmerich J
    Thromb Haemost; 2000 Dec; 84(6):1117-8. PubMed ID: 11154123
    [No Abstract]   [Full Text] [Related]  

  • 3. Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.
    Franco RF; Reitsma PH; Lourenço D; Maffei FH; Morelli V; Tavella MH; Araújo AG; Piccinato CE; Zago MA
    Thromb Haemost; 1999 May; 81(5):676-9. PubMed ID: 10365735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FXIIIVal34Leu, common and risk factors of venous thrombosis in early middle-age Costa Rican patients.
    Salazar-Sánchez L; Leon MP; Cartin M; Schuster G; Wulff K; Schröder W; Jiménez-Arce G; Chacon R; Herrmann FH
    Cell Biochem Funct; 2007; 25(6):739-45. PubMed ID: 17195962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
    Wells PS; Anderson JL; Scarvelis DK; Doucette SP; Gagnon F
    Am J Epidemiol; 2006 Jul; 164(2):101-9. PubMed ID: 16740590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism.
    Corral J; González-Conejero R; Iniesta JA; Rivera J; Martínez C; Vicente V
    Haematologica; 2000 Mar; 85(3):293-7. PubMed ID: 10702819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor XIII val34leu and the risk of myocardial infarction.
    Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA
    Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
    Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
    Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of factor XIII Val34Leu polymorphism in patients affected by spontaneous subconjunctival hemorrhage.
    Parmeggiani F; Costagliola C; Incorvaia C; Gemmati D; D'Angelo S; Tognazzo S; Scapoli GL; Sebastiani A
    Am J Ophthalmol; 2004 Sep; 138(3):481-4. PubMed ID: 15364237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
    de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
    Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
    Van Hylckama Vlieg A; Komanasin N; Ariëns RA; Poort SR; Grant PJ; Bertina RM; Rosendaal FR
    Br J Haematol; 2002 Oct; 119(1):169-75. PubMed ID: 12358922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis.
    Cushman M; Cornell A; Folsom AR; Wang L; Tsai MY; Polak J; Tang Z
    Thromb Res; 2007; 121(3):339-45. PubMed ID: 17582472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XIII-circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease.
    Mills JD; Mansfield MW; Grant PJ
    Thromb Haemost; 2002 Mar; 87(3):409-14. PubMed ID: 11916071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a common polymorphism in the factor XIII gene with venous thrombosis.
    Catto AJ; Kohler HP; Coore J; Mansfield MW; Stickland MH; Grant PJ
    Blood; 1999 Feb; 93(3):906-8. PubMed ID: 9920839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism.
    Le Gal G; Delahousse B; Lacut K; Malaviolle V; Regina S; Blouch MT; Couturaud F; Mottier D; Oger E; Gruel Y;
    Thromb Res; 2007; 121(3):333-8. PubMed ID: 17568659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
    Procare-GEHT Group
    Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
    Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
    Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XIII Val34Leu polymorphism and ischaemic stroke in patients with patent foramen ovale.
    Wypasek E; Stepien E; Pieculewicz M; Podolec P; Undas A
    Thromb Haemost; 2009 Dec; 102(6):1280-2. PubMed ID: 19967163
    [No Abstract]   [Full Text] [Related]  

  • 19. The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies.
    Sucker C; Farokhzad F; Kurschat C; Grabensee B; Scharf RE; Zotz RB; Maruhn-Debowski B; Hetzel GR
    Clin Appl Thromb Hemost; 2009; 15(2):197-200. PubMed ID: 17895511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
    Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
    Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.